Found 201 articles for: "chemotherapy"
Locally Advanced Basal Cell Carcinoma: Two Severe Case Presentations and Review
March 2018 | Volume 17 | Issue 3 | Case Reports | 358 | Copyright © March 2018
Basal cell carcinoma (BCC) is a common skin malignancy comprising 80% of non-melanoma skin cancers.1 Over 2.8 million cases are estimated to be diagnosed in the United States alone each year. Advanced...
Read MoreDupilumab in the Treatment of Dyshidrosis: A Report of Two Cases of Dyshidrotic Eczema
March 2018 | Volume 17 | Issue 3 | Case Reports | 355 | Copyright © March 2018
Dyshidrotic eczema is a distinct entity, often considered on the spectrum of atopic dermatitis, that primarily effec...
Read MoreIntralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review
March 2018 | Volume 17 | Issue 3 | Original Article | 274 | Copyright © March 2018
INTRODUCTION: 5-fluorouracil has proven to be an effective therapy in the treatment of a variety of dermatologic conditions. Approved by the United States Food and Drug Administration for the topical ...
Read MoreVancomycin Infiltrate-Induced Dermatitis Mimicking Bullous Cellulitis
November 2017 | Volume 16 | Issue 11 | Case Reports | 1160 | Copyright © November 2017
Extravasation of medications can manifest as tenderness, pain, tissue necrosis, and thrombophlebitis and lead to infection and severe long-term complications. Risk factors for leakage of medication...
Read MorePort-Wine Stains: A Focused Review on Their Management
November 2017 | Volume 16 | Issue 11 | Original Article | 1145 | Copyright © November 2017
Port-wine stain (PWS) is the second most common congenital vascular malformation characterized as ectatic capillaries and venules in the dermis that clinically appears as a deep red to purple patch...
Read MoreManaging Seborrheic Keratoses: Evolving Strategies for Optimizing Patient Outcomes
November 2017 | Volume 16 | Issue 11 | Original Article | 1064 | Copyright © November 2017
The seborrheic keratosis is the most common benign skin tumor of middle-aged and elderly adults, affecting nearly 83 million individuals in the US alone. Although these are benign lesions, many pat...
Read MoreCosmetic Practitioners Take Huge Risks Purchasing and Administering Illegal Botulinum Toxin Drug Products
September 2017 | Volume 16 | Issue 9 | Editorials | 936 | Copyright © September 2017
In their article “Importing Injectables” in the September 2014 issue of the Journal of Drugs in Dermatology, Dr. Kenneth Beer and Karen Rothschild highlighted the possible harm to patients and pra...
Read MoreLong-term Comparison of a Large Spot Vacuum Assisted Handpiece vs the Small Spot Size Traditional Handpiece of the 800 nm Diode Laser
September 2017 | Volume 16 | Issue 9 | Original Article | 893 | Copyright © September 2017
BACKGROUND The 800 nm long-pulsed diode laser machine is safe and effective for permanent hair reduction. Traditionally, most long-pulsed diode lasers used for hair removal had a relatively small spot...
Read MoreTemporal Association of Herpes Zoster Eruption Post-Aminolevulinic Acid Hydrochloride Photodynamic Therapy for Actinic Keratoses
August 2017 | Volume 16 | Issue 8 | Case Reports | 817 | Copyright © August 2017
Herpes zoster is a common and painful disease caused by the reactivation of the varicella-zoster virus with a higher incidence and severity associated with increasing age as well as compromised imm...
Read MoreEruptive Melanocytic Acral Nevi in the Setting of 6-mercaptopurine Therapy
May 2017 | Volume 16 | Issue 5 | Case Reports | 516 | Copyright © May 2017
Eruptive melanocytic nevi (EMN) are a rare clinical finding characterized by sudden-onset nevi that often present in a grouped distribution. They have been associated with chemotherapy, immunosuppr...
Read MorePhotodynamic Therapy Effectively Treats Actinic Keratoses Without Pre-Illumination Incubation Time
March 2017 | Volume 16 | Issue 3 | Case Reports | 275 | Copyright © March 2017
BACKGROUND: Actinic keratoses (AKs) are dysplastic lesions of the epidermis that have the potential to progress to non-melanoma skin cancers (NMSC). Traditional photodynamic therapy (PDT) requires ...
Read MoreA Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis
March 2017 | Volume 16 | Issue 3 | Original Article | 197 | Copyright © March 2017
BACKGROUND: Psoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression. Treatment options focus on r...
Read MoreCLINICAL TRIAL REVIEW
February 2017 | Volume 16 | Issue 2 | Features | 183 | Copyright © February 2017
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select...
Read MoreThe Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin Barrier
January 2017 | Volume 16 | Issue 1 | Original Article | 12 | Copyright © January 2017
The skin is constantly exposed to various endogenous and exogenous factors that may impact its barrier function at the physical, mechanical, immunological, and microbial levels. These factors have ...
Read MoreSearching for the Best Drug Combination to Treat Melanoma Patients: From Lab to Bedside
December 2016 | Volume 15 | Issue 12 | Editorials | 1580 | Copyright © December 2016
Despite the initial encouraging clinical results that emerged from the vast arsenal of different novel targeted therapies for melanoma, long-term outcomes seem less auspicious. Recently, new drug comb...
Read MoreSelf-Resolving Eruptive Keratoacanthomas After Full-Field Erbium Laser Resurfacing
November 2016 | Volume 15 | Issue 11 | Case Reports | 1453 | Copyright © November 2016
Keratoacanthoma (KA) is a subtype of squamous cell carcinoma whose development has been linked to excessive sun exposure, immunosuppression, and trauma. Given the rapidly expanding therapeutic armamen...
Read MoreTherapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides
December 2015 | Volume 14 | Issue 12 | Features | 1381 | Copyright © December 2015
Resident Rounds: Part III - Primary Cutaneous Mucormycosis
August 2015 | Volume 14 | Issue 8 | Features | 915 | Copyright © August 2015
We present the case of a 36-year-old neutropenic man with acute myelogenous leukemia who presented for evaluation of a rapidly expanding necrotic eschar after adhesive placement. Histopathology reveal...
Read MoreN-acetylcysteine S-nitrosothiol Nanoparticles Prevent Wound Expansion and Accelerate Wound Closure in a Murine Burn Model
July 2015 | Volume 14 | Issue 7 | Original Article | 726 | Copyright © July 2015
BACKGROUND: The treatment of cutaneous wounds in the clinical setting continues to be a clinical challenge and economic burden, with burn wounds being especially formidable. Direct mechanical injury c...
Read MoreClinical Trial Report
June 2015 | Volume 14 | Issue 6 | Features | 643 | Copyright © June 2015
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read More